BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04685499-completion@plaintrial.com
DTSTAMP:20261028T211316Z
DTSTART;VALUE=DATE:20220603
SUMMARY:Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembr
 olizumab and SBRT in Patients With HNSCC With Inoperable\, Recurrent or Pr
 ogressive Disease — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04685499
URL:https://plaintrial.com/trial/NCT04685499
END:VEVENT
END:VCALENDAR